Sigyn Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Sigyn Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2023.
  • Sigyn Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.2M, a 32.2% decline year-over-year.
  • Sigyn Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$3.99M, a 4.3% decline year-over-year.
  • Sigyn Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$4.15M, a 41.5% decline from 2022.
  • Sigyn Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$2.93M, a 2.49% increase from 2021.
  • Sigyn Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$3M, a 139% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4.15M -$1.22M -41.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 -$2.93M +$74.8K +2.49% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 -$3M -$1.75M -139% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$1.26M +$1.82M +59% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 -$3.07M -$454K -17.3% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-30
2018 -$2.62M +$1.63M +38.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$4.25M Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2015 -$2.69M -$2.31M -595% Jan 1, 2015 Dec 31, 2015 10-K 2016-03-30
2014 -$388K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.